Abnormal Mitochondrial Bioenergetic and Motility Signatures in Human Blood Cells as Indices of Acute Poisoning in Patients
人血细胞线粒体生物能和运动特征异常作为患者急性中毒的指标
基本信息
- 批准号:10112290
- 负责人:
- 金额:$ 16.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAffectAgeAirAntidotesAreaBioenergeticsBiological MarkersBlood CellsBlood PlateletsCarbon MonoxideCardiovascular systemCause of DeathCell LineCell RespirationCellsCenters for Disease Control and Prevention (U.S.)Cessation of lifeCharacteristicsClinicalComplexCyanidesDataEffectivenessEmergency Department patientEmergency SituationEmergency department visitEnrollmentEnvironmentEventExhibitsExposure toFire - disastersFunctional disorderFundingFutureGasesGenerationsGoalsGrantHeart ArrestHospitalizationHourHumanHydrogen PeroxideHydrogen SulfideIndustrializationInjuryKnowledgeLinkLiquid substanceMeasurementMeasuresMedicineMentorsMentorshipMethodsMitochondriaMolecularMorbidity - disease rateMovementOccupationalOccupational ExposurePatient CarePatientsPeripheral Blood Mononuclear CellPharmacologyPoisonPoisoningProdrugsProductionPublic HealthPublicationsResearchResearch PersonnelResearch TrainingResolutionRespirationResuscitationResveratrolScienceShockSourceStructureSuccinatesSuicideSupportive careSurrogate MarkersTerrorismTestingTimeTissuesToxic effectToxicologyUnited StatesUnited States National Institutes of HealthWorkbasecell motilityclinical applicationcomplex IVcostcytochrome ceffective therapyexperimental studyfoodbornehealthy volunteerimprovedindexinginhibitor/antagonistinnovationmedical specialtiesminimally invasivemitochondrial dysfunctionmortalitymultidisciplinarynovelpatient populationprospectiveresponserestorationskillstreatment strategywaterborneweapons
项目摘要
Project Summary
Poison-related incidents account for over 450,000 hospitalizations and 750,000 emergency department (ED)
visits, with the yearly cost for ED visits exceeding $550 million. It is conservatively estimated that 5,000 deaths
per year and 20,000 injuries in the US are due to mitochondrial poisons (e.g., carbon monoxide (CO), cyanide
(CN), hydrogen sulfide (H2S), phosphides) resulting in mitochondrial inhibition leading directly to cardiac arrest
and/or shock. Exposure to mitochondrial inhibitors occurs in a variety of settings, including fires, occupational
and industrial exposures, suicide and potential air-, water- and food-borne terrorism agents such as
weaponized gases and liquids. Treatment at this is time is limited and currently depends on supportive care
and use of antidotal therapy of variable effectiveness. The primary cause of death to these mitochondrial
inhibitors is circulatory shock and cardiac arrest. Despite currently available treatments, morbidity and mortality
remains high due to significant gaps in knowledge, including the relationship between mitochondrial
dysfunction in response to acute mitochondrial poisoning and the lack of adequate molecular or cell-based
indices for goal-directed treatment. My long-term goal is to identify characteristic signatures of abnormalities in
mitochondrial bioenergetics and dynamics in human blood cells as well as apply a new pharmacological
strategy of mitochondrial-directed therapy. My central hypothesis, formulated on the basis of my relevant
publications and preliminary data found in this grant, is that there are considerable changes in complex-linked
activity, ROS and dynamics in response to acute poisoning. Also that blood cells may be used a surrogate
marker of mitochondrial dysfunction of affected tissue. At this time there are no clinical tests that directly
measure mitochondrial function in a time-sensitive manner relevant to acute patient care. The experiments
proposed in this application will apply the measurement or assessment of various parameters defining
mitochondrial bioenergetics and dynamics in isolated human blood cells obtained from poisoned patients. We
will also apply a new pharmacologic strategy for mitochondrial directed treatment in human blood cells
exposed to select mitochondrial poisons in a controlled manner. The rationale for the proposed research is
develop a clear understanding of the dysfunction that appears in mitochondrial bioenergetics and motility in
response to mitochondrial poisons and the restoration of normal mitochondrial function that occurs with
implementation of effective treatment.
项目摘要
与中毒有关的事件导致45万多人住院,75万人急诊(艾德)
艾德诊症的费用每年超过5.5亿元。据保守估计,
在美国,每年有20,000例损伤是由于线粒体毒物(例如,一氧化碳(CO)、氰化物
(CN)硫化氢(H2S)、磷化物),导致线粒体抑制,直接导致心脏骤停
和/或休克。暴露于线粒体抑制剂发生在各种环境中,包括火灾,职业
和工业接触,自杀和潜在的空气,水和食物传播的恐怖主义制剂,
武器化气体和液体目前的治疗是有限的,目前取决于支持性护理
以及使用不同有效性的解毒剂治疗。这些线粒体死亡的主要原因
抑制剂是循环休克和心脏骤停。尽管目前有治疗方法,
由于在知识方面存在重大差距,包括线粒体与
对急性线粒体中毒的反应功能障碍和缺乏足够的分子或细胞为基础的
目标导向治疗的指标。我的长期目标是识别出
线粒体生物能量学和动力学在人类血细胞以及应用一种新的药理学
脑靶向治疗策略。我的核心假设,是基于我的相关理论,
出版物和初步数据发现,在这个赠款,是有相当大的变化,复杂的联系,
活性,活性氧和动态响应急性中毒。血细胞也可以作为替代物
受影响组织的线粒体功能障碍的标志物。目前还没有直接的临床试验
以与急性患者护理相关的时间敏感方式测量线粒体功能。实验
本申请中提出的方法将应用各种参数的测量或评估,
从中毒患者获得的分离的人血细胞中的线粒体生物能量学和动力学。我们
还将应用一种新的药理学策略,用于人类血细胞中的线粒体定向治疗
以受控的方式暴露于选择的线粒体毒素。拟议研究的基本原理是
发展一个清楚的理解,出现在线粒体生物能量学和运动功能障碍,
对线粒体毒物的反应和正常线粒体功能的恢复,
实施有效治疗。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Topical nitroglycerin to detect reversible microcirculatory dysfunction in patients with circulatory shock after cardiovascular surgery: an observational study.
- DOI:10.1038/s41598-022-19741-0
- 发表时间:2022-09-10
- 期刊:
- 影响因子:4.6
- 作者:Greenwood, John C.;Talebi, Fatima M.;Jang, David H.;Spelde, Audrey E.;Tonna, Joseph E.;Gutsche, Jacob T.;Horak, Jiri;Acker, Michael A.;Kilbaugh, Todd J.;Shofer, Frances S.;Augoustides, John G. T.;Bakker, Jan;Brenner, Jacob S.;Muzykantov, Vladimir R.;Abella, Benjamin S.
- 通讯作者:Abella, Benjamin S.
Alterations in Mitochondrial Function in Blood Cells Obtained From Patients With Sepsis Presenting to an Emergency Department.
- DOI:10.1097/shk.0000000000001208
- 发表时间:2019-05
- 期刊:
- 影响因子:0
- 作者:Jang DH;Orloski CJ;Owiredu S;Shofer FS;Greenwood JC;Eckmann DM
- 通讯作者:Eckmann DM
JMT's Research Concepts Section: a 5-Year Evaluation.
JMT 的研究概念部分:五年评估。
- DOI:10.1007/s13181-019-00725-y
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Jang,DavidH;Love,JenniferS;Mycyk,MarkB
- 通讯作者:Mycyk,MarkB
Severe Impairment of Microcirculatory Perfused Vessel Density Is Associated With Postoperative Lactate and Acute Organ Injury After Cardiac Surgery.
- DOI:10.1053/j.jvca.2020.04.045
- 发表时间:2021-01
- 期刊:
- 影响因子:2.8
- 作者:Greenwood JC;Jang DH;Hallisey SD;Gutsche JT;Horak J;Acker MA;Bermudez CA;Zhou VL;Chatterjee S;Shofer FS;Kilbaugh TJ;Augoustides JGT;Meyer NJ;Bakker J;Abella BS
- 通讯作者:Abella BS
Protocol for the MicroRESUS study: The impact of circulatory shock and resuscitation on microcirculatory function and mitochondrial respiration after cardiovascular surgery.
- DOI:10.1371/journal.pone.0273349
- 发表时间:2022
- 期刊:
- 影响因子:3.7
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID H JANG其他文献
DAVID H JANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID H JANG', 18)}}的其他基金
The Use of Blood Cells and Optical Cerebral Complex IV Redox States in a Porcine Model of CO Poisoning with Evaluation of Mitochondrial Therapy
血细胞和光脑复合物 IV 氧化还原态在猪 CO 中毒模型中的应用及线粒体治疗的评价
- 批准号:
10734741 - 财政年份:2023
- 资助金额:
$ 16.87万 - 项目类别:
The Use of Blood Cells as a Biomarker in a Porcine Model of CO Poisoning with Evaluation of an Engineered Succinate-Prodrug
使用血细胞作为一氧化碳中毒猪模型中的生物标志物并评估工程琥珀酸前药
- 批准号:
10276252 - 财政年份:2021
- 资助金额:
$ 16.87万 - 项目类别:
Mitochondrial-Directed Therapy in Carbon Monoxide Poisoning
一氧化碳中毒的线粒体定向治疗
- 批准号:
10264056 - 财政年份:2020
- 资助金额:
$ 16.87万 - 项目类别:
Development of a Porcine Model of Carbon Monoxide Poisoning to Evaluate Cardiac and Mitochondrial Dysfunction
开发一氧化碳中毒猪模型以评估心脏和线粒体功能障碍
- 批准号:
10228097 - 财政年份:2020
- 资助金额:
$ 16.87万 - 项目类别:
Mitochondrial-Directed Therapy in Carbon Monoxide Poisoning
一氧化碳中毒的线粒体定向治疗
- 批准号:
10057303 - 财政年份:2020
- 资助金额:
$ 16.87万 - 项目类别:
Development of a Porcine Model of Carbon Monoxide Poisoning to Evaluate Cardiac and Mitochondrial Dysfunction
开发一氧化碳中毒猪模型以评估心脏和线粒体功能障碍
- 批准号:
10063393 - 财政年份:2020
- 资助金额:
$ 16.87万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 16.87万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 16.87万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 16.87万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 16.87万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 16.87万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 16.87万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 16.87万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 16.87万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 16.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 16.87万 - 项目类别:
Operating Grants